Y
Yinxiang Wei
Researcher at Henan University
Publications - 21
Citations - 487
Yinxiang Wei is an academic researcher from Henan University. The author has contributed to research in topics: Internal medicine & Apoptosis. The author has an hindex of 10, co-authored 17 publications receiving 360 citations. Previous affiliations of Yinxiang Wei include Academy of Military Medical Sciences & Zhejiang University.
Papers
More filters
Journal ArticleDOI
A novel IL-23p19/Ebi3 (IL-39) cytokine mediates inflammation in Lupus-like mice.
Xiaoqian Wang,Yinxiang Wei,He Xiao,Xiaoling Liu,Yu Zhang,Gencheng Han,Guojiang Chen,Chunmei Hou,Ning Ma,Beifen Shen,Yan Li,Charles E. Egwuagu,Renxi Wang +12 more
TL;DR: The results show that IL‐39 might contribute to immunopathogenic mechanisms of systemic lupus erythematosus, and could be used as a possible target for its treatment.
Journal ArticleDOI
Gypenosides improve diabetic cardiomyopathy by inhibiting ROS-mediated NLRP3 inflammasome activation.
Hailong Zhang,Xi Chen,Beibei Zong,Hong-Min Yuan,Wang Zhizeng,Yinxiang Wei,Xuance Wang,Guangchao Liu,Jun Zhang,Shulian Li,Guanchang Cheng,Wang Yaohui,Yuanfang Ma +12 more
TL;DR: It is found that high glucose (HG) induced myocardial damage by activating the NLRP3 inflammasome and then promoting IL‐1β and IL‐18 secretion in H9C2 cells and NRVMs and that Gps may be potential and effective drugs for DCM via the inhibition of ROS‐mediated NLRP2 inflam Masome activation.
Journal ArticleDOI
Exosomes with membrane-associated TGF-β1 from gene-modified dendritic cells inhibit murine EAE independently of MHC restriction.
Lei Yu,Fei Yang,Lingling Jiang,Yinghu Chen,Keyi Wang,Feng Xu,Yinxiang Wei,Xuetao Cao,Jianli Wang,Zhijian Cai +9 more
TL;DR: The results indicate that mTGF‐β1‐EXOs possess powerful immunosuppressive ability and can effectively inhibit the development and progression of EAE in different strains of mice.
Journal ArticleDOI
New Use for an Old Drug: Inhibiting ABCG2 with Sorafenib
TL;DR: This study finds the new use for sorafenib, which has a dual-mode action by inducing ABCG2 degradation in lysosome in addition to inhibiting its function, and forms impressive alignment with the pharmacophore hypothesis, supporting the argument that sorafinib is a potentialABCG2 inhibitor.
Journal ArticleDOI
Activated cytotoxic lymphocytes promote tumor progression by increasing the ability of 3LL tumor cells to mediate MDSC chemoattraction via Fas signaling.
Fei Yang,Yinxiang Wei,Zhijian Cai,Lei Yu,Lingling Jiang,Chengyan Zhang,Huanmiao Yan,Qingqing Wang,Xuetao Cao,Tingbo Liang,Jianli Wang +10 more
TL;DR: It is found that CTLs induced tumor cells to secrete PGE2 and increase tumor cell-mediated chemoattraction of MDSCs via Fas signaling, which was favorable to tumor growth.